img

Global Gene Therapy on Neurological Diseases Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Gene Therapy on Neurological Diseases Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application

Gene therapy is an experimental technique that uses genes to treat or prevent disease. In the future, this technique may allow doctors to treat a disorder by inserting a gene into a patient's cells instead of using drugs or surgery.
Gene Therapy on Neurological Diseases report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Gene Therapy on Neurological Diseases market is projected to reach US$ 12190 million in 2029, increasing from US$ 4347 million in 2022, with the CAGR of 16.0% during the period of 2024 to 2029. Demand from Hospital and Clinic are the major drivers for the industry.
The Drug Based on Gene Therapy market is primarily driven by the revolutionary potential of gene therapy to address genetic disorders at their root cause, offering a new paradigm for treating previously incurable conditions. Gene therapy involves introducing genetic material into a patient's cells to correct or replace faulty genes, aiming to restore normal cellular function. The increasing understanding of the genetic basis of diseases, coupled with advancements in gene delivery methods and genome editing techniques, contributes to market growth. Moreover, the demonstrated benefits of gene therapy in providing targeted and long-lasting treatments, overcoming limitations of traditional pharmacological approaches, and offering hope to patients with rare genetic disorders further propel adoption. However, challenges include optimizing gene delivery efficiency, addressing potential immune responses, and ensuring the long-term safety and durability of gene-based treatments. Navigating regulatory pathways, conducting rigorous clinical trials, and addressing ethical considerations are ongoing concerns. The market's success relies on continuous research in genetic medicine, collaborations between biotechnology companies and research institutions, and comprehensive education on the benefits and potential challenges of using gene therapy-based drugs while addressing the evolving challenges associated with precision medicine and personalized treatments.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Gene Therapy on Neurological Diseases market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report



By Company


Biogen
Novartis
Sarepta Therapeutics
Segment by Type
Viral Gene Therapy
Non-viral Gene Therapy

Segment by Application


Hospital
Clinic
Other
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries

Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia

Latin America
Mexico
Brazil

Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Gene Therapy on Neurological Diseases market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2024, 2024-2029).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Gene Therapy on Neurological Diseases introduction, etc. Gene Therapy on Neurological Diseases Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12Mr Accuracy reports’s Conclusions of Gene Therapy on Neurological Diseases market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports.

Table of Content

1 Market Overview of Gene Therapy on Neurological Diseases
1.1 Gene Therapy on Neurological Diseases Market Overview
1.1.1 Gene Therapy on Neurological Diseases Product Scope
1.1.2 Gene Therapy on Neurological Diseases Market Status and Outlook
1.2 Global Gene Therapy on Neurological Diseases Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Gene Therapy on Neurological Diseases Market Size by Region (2018-2029)
1.4 Global Gene Therapy on Neurological Diseases Historic Market Size by Region (2018-2024)
1.5 Global Gene Therapy on Neurological Diseases Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Gene Therapy on Neurological Diseases Market Size (2018-2029)
1.6.1 North America Gene Therapy on Neurological Diseases Market Size (2018-2029)
1.6.2 Europe Gene Therapy on Neurological Diseases Market Size (2018-2029)
1.6.3 Asia-Pacific Gene Therapy on Neurological Diseases Market Size (2018-2029)
1.6.4 Latin America Gene Therapy on Neurological Diseases Market Size (2018-2029)
1.6.5 Middle East & Africa Gene Therapy on Neurological Diseases Market Size (2018-2029)
2 Gene Therapy on Neurological Diseases Market by Type
2.1 Introduction
2.1.1 Viral Gene Therapy
2.1.2 Non-viral Gene Therapy
2.2 Global Gene Therapy on Neurological Diseases Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Gene Therapy on Neurological Diseases Historic Market Size by Type (2018-2024)
2.2.2 Global Gene Therapy on Neurological Diseases Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Gene Therapy on Neurological Diseases Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Gene Therapy on Neurological Diseases Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Gene Therapy on Neurological Diseases Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Gene Therapy on Neurological Diseases Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Gene Therapy on Neurological Diseases Revenue Breakdown by Type (2018-2029)
3 Gene Therapy on Neurological Diseases Market Overview by Application
3.1 Introduction
3.1.1 Hospital
3.1.2 Clinic
3.1.3 Other
3.2 Global Gene Therapy on Neurological Diseases Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Gene Therapy on Neurological Diseases Historic Market Size by Application (2018-2024)
3.2.2 Global Gene Therapy on Neurological Diseases Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Gene Therapy on Neurological Diseases Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Gene Therapy on Neurological Diseases Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Gene Therapy on Neurological Diseases Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Gene Therapy on Neurological Diseases Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Gene Therapy on Neurological Diseases Revenue Breakdown by Application (2018-2029)
4 Gene Therapy on Neurological Diseases Competition Analysis by Players
4.1 Global Gene Therapy on Neurological Diseases Market Size by Players (2018-2024)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Gene Therapy on Neurological Diseases as of 2022)
4.3 Date of Key Players Enter into Gene Therapy on Neurological Diseases Market
4.4 Global Top Players Gene Therapy on Neurological Diseases Headquarters and Area Served
4.5 Key Players Gene Therapy on Neurological Diseases Product Solution and Service
4.6 Competitive Status
4.6.1 Gene Therapy on Neurological Diseases Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Biogen
5.1.1 Biogen Profile
5.1.2 Biogen Main Business
5.1.3 Biogen Gene Therapy on Neurological Diseases Products, Services and Solutions
5.1.4 Biogen Gene Therapy on Neurological Diseases Revenue (US$ Million) & (2018-2024)
5.1.5 Biogen Recent Developments
5.2 Novartis
5.2.1 Novartis Profile
5.2.2 Novartis Main Business
5.2.3 Novartis Gene Therapy on Neurological Diseases Products, Services and Solutions
5.2.4 Novartis Gene Therapy on Neurological Diseases Revenue (US$ Million) & (2018-2024)
5.2.5 Novartis Recent Developments
5.3 Sarepta Therapeutics
5.3.1 Sarepta Therapeutics Profile
5.3.2 Sarepta Therapeutics Main Business
5.3.3 Sarepta Therapeutics Gene Therapy on Neurological Diseases Products, Services and Solutions
5.3.4 Sarepta Therapeutics Gene Therapy on Neurological Diseases Revenue (US$ Million) & (2018-2024)
5.3.5 Recent Developments
6 North America
6.1 North America Gene Therapy on Neurological Diseases Market Size by Country (2018-2029)
6.2 United States
6.3 Canada
7 Europe
7.1 Europe Gene Therapy on Neurological Diseases Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Gene Therapy on Neurological Diseases Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Gene Therapy on Neurological Diseases Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Gene Therapy on Neurological Diseases Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Gene Therapy on Neurological Diseases Market Dynamics
11.1 Gene Therapy on Neurological Diseases Industry Trends
11.2 Gene Therapy on Neurological Diseases Market Drivers
11.3 Gene Therapy on Neurological Diseases Market Challenges
11.4 Gene Therapy on Neurological Diseases Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List

List of Figure

List of Tables
Table 1. Global Market Gene Therapy on Neurological Diseases Market Size (US$ Million) Comparison by Region 2018 VS 2022 VS 2029
Table 2. Global Gene Therapy on Neurological Diseases Market Size by Region (2018-2024) & (US$ Million)
Table 3. Global Gene Therapy on Neurological Diseases Market Size Share by Region (2018-2024)
Table 4. Global Gene Therapy on Neurological Diseases Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 5. Global Gene Therapy on Neurological Diseases Forecasted Market Size Share by Region (2024-2029)
Table 6. Global Gene Therapy on Neurological Diseases Market Size (US$ Million) by Type: 2018 VS 2022 VS 2029
Table 7. Global Gene Therapy on Neurological Diseases Market Size by Type (2018-2024) & (US$ Million)
Table 8. Global Gene Therapy on Neurological Diseases Revenue Market Share by Type (2018-2024)
Table 9. Global Gene Therapy on Neurological Diseases Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 10. Global Gene Therapy on Neurological Diseases Revenue Market Share by Type (2024-2029)
Table 11. North America Gene Therapy on Neurological Diseases Revenue by Type (2018-2024) & (US$ Million)
Table 12. North America Gene Therapy on Neurological Diseases Revenue by Type (2024-2029) & (US$ Million)
Table 13. Europe Gene Therapy on Neurological Diseases Revenue by Type (2018-2024) & (US$ Million)
Table 14. Europe Gene Therapy on Neurological Diseases Revenue by Type (2024-2029) & (US$ Million)
Table 15. Asia-Pacific Gene Therapy on Neurological Diseases Revenue by Type (2018-2024) & (US$ Million)
Table 16. Asia-Pacific Gene Therapy on Neurological Diseases Revenue by Type (2024-2029) & (US$ Million)
Table 17. Latin America Gene Therapy on Neurological Diseases Revenue by Type (2018-2024) & (US$ Million)
Table 18. Latin America Gene Therapy on Neurological Diseases Revenue by Type (2024-2029) & (US$ Million)
Table 19. Middle East and Africa Gene Therapy on Neurological Diseases Revenue by Type (2018-2024) & (US$ Million)
Table 20. Middle East and Africa Gene Therapy on Neurological Diseases Revenue by Type (2024-2029) & (US$ Million)
Table 21. Global Gene Therapy on Neurological Diseases Market Size (US$ Million) by Application: 2018 VS 2022 VS 2029
Table 22. Global Gene Therapy on Neurological Diseases Market Size by Application (2018-2024) & (US$ Million)
Table 23. Global Gene Therapy on Neurological Diseases Revenue Market Share by Application (2018-2024)
Table 24. Global Gene Therapy on Neurological Diseases Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 25. Global Gene Therapy on Neurological Diseases Revenue Market Share by Application (2024-2029)
Table 26. North America Gene Therapy on Neurological Diseases Revenue by Application (2018-2024) & (US$ Million)
Table 27. North America Gene Therapy on Neurological Diseases Revenue by Application (2024-2029) & (US$ Million)
Table 28. Europe Gene Therapy on Neurological Diseases Revenue by Application (2018-2024) & (US$ Million)
Table 29. Europe Gene Therapy on Neurological Diseases Revenue by Application (2024-2029) & (US$ Million)
Table 30. Asia-Pacific Gene Therapy on Neurological Diseases Revenue by Application (2018-2024) & (US$ Million)
Table 31. Asia-Pacific Gene Therapy on Neurological Diseases Revenue by Application (2024-2029) & (US$ Million)
Table 32. Latin America Gene Therapy on Neurological Diseases Revenue by Application (2018-2024) & (US$ Million)
Table 33. Latin America Gene Therapy on Neurological Diseases Revenue by Application (2024-2029) & (US$ Million)
Table 34. Middle East and Africa Gene Therapy on Neurological Diseases Revenue by Application (2018-2024) & (US$ Million)
Table 35. Middle East and Africa Gene Therapy on Neurological Diseases Revenue by Application (2024-2029) & (US$ Million)
Table 36. Global Gene Therapy on Neurological Diseases Revenue (US$ Million) by Players (2018-2024)
Table 37. Global Gene Therapy on Neurological Diseases Revenue Market Share by Players (2018-2024)
Table 38. Global Top Players Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Gene Therapy on Neurological Diseases as of 2022)
Table 39. Date of Key Players Enter into Gene Therapy on Neurological Diseases Market
Table 40. Global Gene Therapy on Neurological Diseases Key Players Headquarters and Area Served
Table 41. Gene Therapy on Neurological Diseases Product Solution and Service
Table 42. Global Gene Therapy on Neurological Diseases Players Market Concentration Ratio (CR5 and HHI)
Table 43. Mergers & Acquisitions, Expansion Plans
Table 44. Biogen Basic Information List
Table 45. Biogen Description and Business Overview
Table 46. Biogen Gene Therapy on Neurological Diseases Products, Services and Solutions
Table 47. Revenue (US$ Million) in Gene Therapy on Neurological Diseases Business of Biogen (2018-2024)
Table 48. Biogen Recent Developments
Table 49. Novartis Basic Information List
Table 50. Novartis Description and Business Overview
Table 51. Novartis Gene Therapy on Neurological Diseases Products, Services and Solutions
Table 52. Revenue (US$ Million) in Gene Therapy on Neurological Diseases Business of Novartis (2018-2024)
Table 53. Novartis Recent Developments
Table 54. Sarepta Therapeutics Basic Information List
Table 55. Sarepta Therapeutics Description and Business Overview
Table 56. Sarepta Therapeutics Gene Therapy on Neurological Diseases Products, Services and Solutions
Table 57. Revenue (US$ Million) in Gene Therapy on Neurological Diseases Business of Sarepta Therapeutics (2018-2024)
Table 58. Sarepta Therapeutics Recent Developments
Table 59. North America Gene Therapy on Neurological Diseases Market Size by Country (2018-2024) & (US$ Million)
Table 60. North America Gene Therapy on Neurological Diseases Market Size by Country (2024-2029) & (US$ Million)
Table 61. Europe Gene Therapy on Neurological Diseases Market Size by Country (2018-2024) & (US$ Million)
Table 62. Europe Gene Therapy on Neurological Diseases Market Size by Country (2024-2029) & (US$ Million)
Table 63. Asia-Pacific Gene Therapy on Neurological Diseases Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 64. Asia-Pacific Gene Therapy on Neurological Diseases Market Size by Region (2018-2024) & (US$ Million)
Table 65. Asia-Pacific Gene Therapy on Neurological Diseases Market Size by Region (2024-2029) & (US$ Million)
Table 66. Asia-Pacific Gene Therapy on Neurological Diseases Market Share by Region (2018-2024)
Table 67. Asia-Pacific Gene Therapy on Neurological Diseases Market Share by Region (2024-2029)
Table 68. Latin America Gene Therapy on Neurological Diseases Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 69. Latin America Gene Therapy on Neurological Diseases Market Size by Country (2018-2024) & (US$ Million)
Table 70. Latin America Gene Therapy on Neurological Diseases Market Size by Country (2024-2029) & (US$ Million)
Table 71. Middle East & Africa Gene Therapy on Neurological Diseases Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 72. Middle East & Africa Gene Therapy on Neurological Diseases Market Size by Country (2018-2024) & (US$ Million)
Table 73. Middle East & Africa Gene Therapy on Neurological Diseases Market Size by Country (2024-2029) & (US$ Million)
Table 74. Gene Therapy on Neurological Diseases Market Trends
Table 75. Gene Therapy on Neurological Diseases Market Drivers
Table 76. Gene Therapy on Neurological Diseases Market Challenges
Table 77. Gene Therapy on Neurological Diseases Market Restraints
Table 78. Research Programs/Design for This Report
Table 79. Key Data Information from Secondary Sources
Table 80. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Gene Therapy on Neurological Diseases Market Size Year-over-Year 2018-2029 & (US$ Million)
Figure 2. Global Gene Therapy on Neurological Diseases Market Size (US$ Million), 2018 VS 2022 VS 2029
Figure 3. Global Gene Therapy on Neurological Diseases Market Share by Regions: 2022 VS 2029
Figure 4. Global Gene Therapy on Neurological Diseases Forecasted Market Size Share by Region (2024-2029)
Figure 5. North America Gene Therapy on Neurological Diseases Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 6. Europe Gene Therapy on Neurological Diseases Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 7. Asia-Pacific Gene Therapy on Neurological Diseases Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 8. Latin America Gene Therapy on Neurological Diseases Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 9. Middle East & Africa Gene Therapy on Neurological Diseases Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 10. Product Picture of Viral Gene Therapy
Figure 11. Global Viral Gene Therapy Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 12. Product Picture of Non-viral Gene Therapy
Figure 13. Global Non-viral Gene Therapy Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 14. Global Gene Therapy on Neurological Diseases Market Size Share by Type: 2022 & 2029
Figure 15. North America Gene Therapy on Neurological Diseases Revenue Market Share by Type (2018-2029)
Figure 16. Europe Gene Therapy on Neurological Diseases Revenue Market Share by Type (2018-2029)
Figure 17. Asia-Pacific Gene Therapy on Neurological Diseases Revenue Market Share by Type (2018-2029)
Figure 18. Latin America Gene Therapy on Neurological Diseases Revenue Market Share by Type (2018-2029)
Figure 19. Middle East and Africa Gene Therapy on Neurological Diseases Revenue Market Share by Type (2018-2029)
Figure 20. Hospital Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 21. Clinic Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 22. Other Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 23. Global Gene Therapy on Neurological Diseases Market Size Share by Application: 2022 & 2029
Figure 24. North America Gene Therapy on Neurological Diseases Revenue Market Share by Application (2018-2029)
Figure 25. Europe Gene Therapy on Neurological Diseases Revenue Market Share by Application (2018-2029)
Figure 26. Asia-Pacific Gene Therapy on Neurological Diseases Revenue Market Share by Application (2018-2029)
Figure 27. Latin America Gene Therapy on Neurological Diseases Revenue Market Share by Application (2018-2029)
Figure 28. Middle East and Africa Gene Therapy on Neurological Diseases Revenue Market Share by Application (2018-2029)
Figure 29. Gene Therapy on Neurological Diseases Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 30. Global Top 5 and Top 10 Players Gene Therapy on Neurological Diseases Market Share in 2022
Figure 31. North America Gene Therapy on Neurological Diseases Market Share by Country (2018-2029)
Figure 32. United States Gene Therapy on Neurological Diseases Market Size (2018-2029) & (US$ Million)
Figure 33. Canada Gene Therapy on Neurological Diseases Market Size (2018-2029) & (US$ Million)
Figure 34. Germany Gene Therapy on Neurological Diseases Market Size (2018-2029) & (US$ Million)
Figure 35. France Gene Therapy on Neurological Diseases Market Size (2018-2029) & (US$ Million)
Figure 36. U.K. Gene Therapy on Neurological Diseases Market Size (2018-2029) & (US$ Million)
Figure 37. Italy Gene Therapy on Neurological Diseases Market Size (2018-2029) & (US$ Million)
Figure 38. Russia Gene Therapy on Neurological Diseases Market Size (2018-2029) & (US$ Million)
Figure 39. Nordic Countries Gene Therapy on Neurological Diseases Market Size (2018-2029) & (US$ Million)
Figure 40. Asia-Pacific Gene Therapy on Neurological Diseases Market Share by Region (2018-2029)
Figure 41. China Gene Therapy on Neurological Diseases Market Size (2018-2029) & (US$ Million)
Figure 42. Japan Gene Therapy on Neurological Diseases Market Size (2018-2029) & (US$ Million)
Figure 43. South Korea Gene Therapy on Neurological Diseases Market Size (2018-2029) & (US$ Million)
Figure 44. Southeast Asia Gene Therapy on Neurological Diseases Market Size (2018-2029) & (US$ Million)
Figure 45. India Gene Therapy on Neurological Diseases Market Size (2018-2029) & (US$ Million)
Figure 46. Australia Gene Therapy on Neurological Diseases Market Size (2018-2029) & (US$ Million)
Figure 47. Latin America Gene Therapy on Neurological Diseases Market Share by Country (2018-2029)
Figure 48. Mexico Gene Therapy on Neurological Diseases Market Size (2018-2029) & (US$ Million)
Figure 49. Brazil Gene Therapy on Neurological Diseases Market Size (2018-2029) & (US$ Million)
Figure 50. Middle East & Africa Gene Therapy on Neurological Diseases Market Share by Country (2018-2029)
Figure 51. Turkey Gene Therapy on Neurological Diseases Market Size (2018-2029) & (US$ Million)
Figure 52. Saudi Arabia Gene Therapy on Neurological Diseases Market Size (2018-2029) & (US$ Million)
Figure 53. UAE Gene Therapy on Neurological Diseases Market Size (2018-2029) & (US$ Million)
Figure 54. Bottom-up and Top-down Approaches for This Report

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries